20 ML epinephrine 0.005 MG/ML / lidocaine hydrochloride 20 MG/ML Injection [Xylocaine with Epinephrine]
- RxCUI
- 1010692
- RxNorm name
- 20 ML epinephrine 0.005 MG/ML / lidocaine hydrochloride 20 MG/ML Injection [Xylocaine with Epinephrine]
- Display name
- XYLOCAINE WITH EPINEPHrine (Injectable)
- Full name
- 20 ML epinephrine 0.005 MG/ML / lidocaine hydrochloride 20 MG/ML Injection [Xylocaine with Epinephrine]
- Term type
- SBD
- Status
- Active
- Strength
- 0.005-20 mg/ml
- Dose form
- Injection 20 ml
- Route
- Injectable
- Updated
- 2026-06-16 07:05:27
RxNorm Status History#
- Status
- Active
- Source
- RXNORM
- Current
- YES
- Release start
- 102010
- Active start
- 102010
- Multiple ingredient
- YES
- Branded
- YES
Ingredients And Strength#
Derived Ingredient Concepts#
FDA NDC Products And Packages#
Package NDC, Product NDC, Name table| Package NDC | Product NDC | Name | Labeler | Application |
|---|
| 0404-9972-20 | 0404-9972 | Xylocaine Lidocaine Hydrochloride and epinephrine | Henry Schein, Inc. | NDA006488 |
| 63323-489-21 | 63323-489 | Xylocaine LIDOCAINE HYDROCHLORIDE,EPINEPHRINE BITARTRATE | Fresenius Kabi USA, LLC | NDA006488 |
| 63323-489-27 | 63323-489 | Xylocaine LIDOCAINE HYDROCHLORIDE,EPINEPHRINE BITARTRATE | Fresenius Kabi USA, LLC | NDA006488 |
Drugs@FDA Applications#
Application, NDC, Name table| Application | NDC | Name | Marketing category | Labeler |
|---|
| NDA006488 | 0404-9972 | Xylocaine Lidocaine Hydrochloride and epinephrine | NDA | Henry Schein, Inc. |
RxNav Current And Historical NDCs#
NDC11, Source, Active table| NDC11 | Source | Active |
|---|
| 00404997220 | rxnav_ndcs | yes |
| 63323048902 | rxnav_ndcs | yes |
| 63323048903 | rxnav_ndcs | yes |
| 63323048921 | rxnav_ndcs | yes |
| 63323048927 | rxnav_ndcs | yes |
| 00186012201 | rxnav_historical | |
| 00186012212 | rxnav_historical | |
| 00186012213 | rxnav_historical | |
| 00186012291 | rxnav_historical | |
| 00186025002 | rxnav_historical | |
| 50090332101 | rxnav_historical | |
| 52584048927 | rxnav_historical | |
| 55154956808 | rxnav_historical | |
| 63323048910 | rxnav_historical | |
| 63323048917 | rxnav_historical | |
| 63323048920 | rxnav_historical | |
| 63323048991 | rxnav_historical | |
DailyMed RxNorm Mappings#
Set ID, RxNorm string, TTY table| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|
| ba082c2f-64f4-419d-9c88-74f203316e17 | Xylocaine 2 % / EPINEPHrine 1:200,000 in 20 ML Injection | PSN | 13 | Xylocaine® (lidocaine HCl Injection, USP) Xylocaine® (lidocaine HCl and epinephrine Injection, USP) | 20210825 |
| ba082c2f-64f4-419d-9c88-74f203316e17 | Xylocaine 2 % / EPINEPHrine 1:200,000 per 20 ML Injection | SY | 13 | Xylocaine® (lidocaine HCl Injection, USP) Xylocaine® (lidocaine HCl and epinephrine Injection, USP) | 20210825 |
| ba082c2f-64f4-419d-9c88-74f203316e17 | 20 ML epinephrine 0.005 MG/ML / lidocaine hydrochloride 20 MG/ML Injection [Xylocaine with Epinephrine] | SBD | 13 | Xylocaine® (lidocaine HCl Injection, USP) Xylocaine® (lidocaine HCl and epinephrine Injection, USP) | 20210825 |
| cfcc8a07-b40c-476d-9a21-83487318ac85 | Xylocaine 2 % / EPINEPHrine 1:200,000 in 20 ML Injection | PSN | 6 | Xylocaine MPF 2% (lidocaine hcl and epinephrine 1:200,00) 20mg/ml 20mL single dose vial | 20251107 |
| cfcc8a07-b40c-476d-9a21-83487318ac85 | Xylocaine 2 % / EPINEPHrine 1:200,000 per 20 ML Injection | SY | 6 | Xylocaine MPF 2% (lidocaine hcl and epinephrine 1:200,00) 20mg/ml 20mL single dose vial | 20251107 |
| cfcc8a07-b40c-476d-9a21-83487318ac85 | 20 ML epinephrine 0.005 MG/ML / lidocaine hydrochloride 20 MG/ML Injection [Xylocaine with Epinephrine] | SBD | 6 | Xylocaine MPF 2% (lidocaine hcl and epinephrine 1:200,00) 20mg/ml 20mL single dose vial | 20251107 |
| 307e29b4-bcc1-4393-ab72-0687843bd1e3 | 20 ML epinephrine 0.005 MG/ML / lidocaine hydrochloride 20 MG/ML Injection [Xylocaine with Epinephrine] | SBD | 2 | Xylocaine® (lidocaine HCl Injection, USP) Xylocaine® (lidocaine HCl and epinephrine Injection, USP) | 20190925 |
| 307e29b4-bcc1-4393-ab72-0687843bd1e3 | Xylocaine 2 % / EPINEPHrine 1:200,000 in 20 ML Injection | PSN | 2 | Xylocaine® (lidocaine HCl Injection, USP) Xylocaine® (lidocaine HCl and epinephrine Injection, USP) | 20190925 |
| 307e29b4-bcc1-4393-ab72-0687843bd1e3 | Xylocaine 2 % / EPINEPHrine 1:200,000 per 20 ML Injection | SY | 2 | Xylocaine® (lidocaine HCl Injection, USP) Xylocaine® (lidocaine HCl and epinephrine Injection, USP) | 20190925 |
DailyMed Labels#
Set ID, Title, Manufacturer table| Set ID | Title | Manufacturer | Effective |
|---|
| cfcc8a07-b40c-476d-9a21-83487318ac85 | Xylocaine MPF 2% (lidocaine hcl and epinephrine 1:200,00) 20mg/ml 20mL single dose vial | Henry Schein, Inc. | 20251107 |
| cfcc8a07-b40c-476d-9a21-83487318ac85 | Xylocaine MPF 2% (lidocaine hcl and epinephrine 1:200,00) 20mg/ml 20mL single dose vial | Henry Schein, Inc. | 20240515 |
| ba082c2f-64f4-419d-9c88-74f203316e17 | Xylocaine® (lidocaine HCl Injection, USP) Xylocaine® (lidocaine HCl and epinephrine Injection, USP) | Fresenius Kabi USA, LLC | Fresenius Kabi Austria | 20210825 |
| 307e29b4-bcc1-4393-ab72-0687843bd1e3 | Xylocaine® (lidocaine HCl Injection, USP) Xylocaine® (lidocaine HCl and epinephrine Injection, USP) | A-S Medication Solutions | 20190925 |
Drug Classes#
Source, Class ID, Class table| Source | Class ID | Class | Type | Relationship | Drug concept |
|---|
| ATC | C01CA | Adrenergic and dopaminergic agents | ATC1-4 | | epinephrine |
| ATC | R03AA | Alpha- and beta-adrenoreceptor agonists | ATC1-4 | | epinephrine |
| ATC | N01BB | Amides | ATC1-4 | | lidocaine |
| ATC | S02DA | Analgesics and anesthetics | ATC1-4 | | lidocaine |
| ATC | D04AB | Anesthetics for topical use | ATC1-4 | | lidocaine |
| ATC | R02AD | Anesthetics, local | ATC1-4 | | lidocaine |
| ATC | C01BB | Antiarrhythmics, class Ib | ATC1-4 | | lidocaine |
| ATC | C05AD | Local anesthetics | ATC1-4 | | lidocaine |
| ATC | S01HA | Local anesthetics | ATC1-4 | | lidocaine |
| ATC | B02BC | Local hemostatics | ATC1-4 | | epinephrine |
| ATC | A01AD | Other agents for local oral treatment | ATC1-4 | | epinephrine |
| ATC | S01EA | Sympathomimetics in glaucoma therapy | ATC1-4 | | epinephrine |
| ATC | R01AA | Sympathomimetics, plain | ATC1-4 | | epinephrine |
| FDASPL | D002395 | Catecholamines | CHEM | has_chemical_structure | epinephrine |
| FDASPL | N0000175552 | alpha-Adrenergic Agonist | EPC | has_epc | epinephrine |
| FDASPL | N0000175682 | Amide Local Anesthetic | EPC | has_epc | lidocaine |
| FDASPL | N0000175426 | Antiarrhythmic | EPC | has_epc | lidocaine |
| FDASPL | N0000175555 | beta-Adrenergic Agonist | EPC | has_epc | epinephrine |
| FDASPL | N0000175570 | Catecholamine | EPC | has_epc | epinephrine |
| FDASPL | N0000000209 | Adrenergic alpha-Agonists | MOA | has_moa | epinephrine |
| FDASPL | N0000000245 | Adrenergic beta-Agonists | MOA | has_moa | epinephrine |
| FDASPL | N0000175976 | Local Anesthesia | PE | has_pe | lidocaine |
| MEDRT | D004837 | Epinephrine | CHEM | has_ingredient | epinephrine |
| MEDRT | D008012 | Lidocaine | CHEM | has_ingredient | lidocaine hydrochloride |
| MEDRT | D008012 | Lidocaine | CHEM | has_ingredient | lidocaine |
| MEDRT | D000219 | Adams-Stokes Syndrome | DISEASE | ci_with | lidocaine hydrochloride |
| MEDRT | D000219 | Adams-Stokes Syndrome | DISEASE | ci_with | lidocaine |
| MEDRT | D000402 | Airway Obstruction | DISEASE | may_treat | epinephrine |
| MEDRT | D000707 | Anaphylaxis | DISEASE | may_treat | epinephrine |
| MEDRT | D001145 | Arrhythmias, Cardiac | DISEASE | ci_with | epinephrine |
| MEDRT | D001919 | Bradycardia | DISEASE | may_treat | epinephrine |
| MEDRT | D001986 | Bronchial Spasm | DISEASE | may_treat | epinephrine |
| MEDRT | D002056 | Burns | DISEASE | may_treat | lidocaine |
| MEDRT | D002056 | Burns | DISEASE | may_treat | lidocaine hydrochloride |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | epinephrine |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | lidocaine |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | lidocaine hydrochloride |
| MEDRT | D064420 | Drug-Related Side Effects and Adverse Reactions | DISEASE | may_treat | lidocaine hydrochloride |
| MEDRT | D064420 | Drug-Related Side Effects and Adverse Reactions | DISEASE | may_treat | lidocaine |
| MEDRT | D004935 | Esophageal Diseases | DISEASE | may_treat | lidocaine |
| MEDRT | D004935 | Esophageal Diseases | DISEASE | may_treat | lidocaine hydrochloride |
| MEDRT | D015812 | Glaucoma, Angle-Closure | DISEASE | ci_with | epinephrine |
| MEDRT | D005902 | Glaucoma, Open-Angle | DISEASE | may_treat | epinephrine |
| MEDRT | D006323 | Heart Arrest | DISEASE | may_treat | epinephrine |
| MEDRT | D006327 | Heart Block | DISEASE | may_treat | epinephrine |
| MEDRT | D006967 | Hypersensitivity | DISEASE | ci_with | lidocaine hydrochloride |
| MEDRT | D006967 | Hypersensitivity | DISEASE | ci_with | lidocaine |
| MEDRT | D007022 | Hypotension | DISEASE | may_treat | epinephrine |
| MEDRT | D009059 | Mouth Diseases | DISEASE | may_treat | lidocaine |
| MEDRT | D009059 | Mouth Diseases | DISEASE | may_treat | lidocaine hydrochloride |
| MEDRT | D009203 | Myocardial Infarction | DISEASE | may_treat | lidocaine hydrochloride |
| MEDRT | D010146 | Pain | DISEASE | may_prevent | lidocaine |
| MEDRT | D010146 | Pain | DISEASE | may_prevent | lidocaine hydrochloride |
| MEDRT | D010146 | Pain | DISEASE | may_treat | lidocaine |
| MEDRT | D010146 | Pain | DISEASE | may_treat | lidocaine hydrochloride |
| MEDRT | D012772 | Shock, Septic | DISEASE | may_treat | epinephrine |
| MEDRT | D013614 | Tachycardia, Paroxysmal | DISEASE | may_treat | lidocaine |
| MEDRT | D013614 | Tachycardia, Paroxysmal | DISEASE | may_treat | lidocaine hydrochloride |
| MEDRT | D017180 | Tachycardia, Ventricular | DISEASE | may_treat | epinephrine |
| MEDRT | D017180 | Tachycardia, Ventricular | DISEASE | may_treat | lidocaine hydrochloride |
| MEDRT | D017180 | Tachycardia, Ventricular | DISEASE | may_treat | lidocaine |
| MEDRT | D018754 | Ventricular Dysfunction | DISEASE | may_treat | lidocaine hydrochloride |
| MEDRT | D014693 | Ventricular Fibrillation | DISEASE | may_treat | epinephrine |
| MEDRT | D014693 | Ventricular Fibrillation | DISEASE | may_treat | lidocaine |
| MEDRT | D014693 | Ventricular Fibrillation | DISEASE | may_treat | lidocaine hydrochloride |
| MEDRT | D018879 | Ventricular Premature Complexes | DISEASE | may_treat | lidocaine hydrochloride |
| MEDRT | D018879 | Ventricular Premature Complexes | DISEASE | may_treat | lidocaine |
| MEDRT | N0000000209 | Adrenergic alpha-Agonists | MOA | has_moa | epinephrine |
| MEDRT | N0000009921 | Adrenergic beta1-Agonists | MOA | has_moa | epinephrine |
| MEDRT | N0000009922 | Adrenergic beta2-Agonists | MOA | has_moa | epinephrine |
| MEDRT | N0000000180 | Sodium Channel Interactions | MOA | has_moa | lidocaine |
| MEDRT | N0000000180 | Sodium Channel Interactions | MOA | has_moa | lidocaine hydrochloride |
| MEDRT | N0000008298 | Arterial Vasoconstriction | PE | has_pe | epinephrine |
| MEDRT | N0000008322 | Bronchodilation | PE | has_pe | epinephrine |
| MEDRT | N0000008330 | Cardiac Rhythm Alteration | PE | has_pe | lidocaine |
| MEDRT | N0000008330 | Cardiac Rhythm Alteration | PE | has_pe | lidocaine hydrochloride |
| MEDRT | N0000008472 | Decreased Cardiac Muscle Organized Electrical Activity | PE | has_pe | lidocaine hydrochloride |
| MEDRT | N0000008472 | Decreased Cardiac Muscle Organized Electrical Activity | PE | has_pe | lidocaine |
| MEDRT | N0000009944 | Decreased Intraocular Aqueous Secretion | PE | has_pe | epinephrine |
| MEDRT | N0000008889 | Decreased Sensory-Somatic Nervous System Organized Electrical Activity | PE | has_pe | lidocaine |
| MEDRT | N0000008889 | Decreased Sensory-Somatic Nervous System Organized Electrical Activity | PE | has_pe | lidocaine hydrochloride |
| MEDRT | N0000009014 | Decreased Uterine Smooth Muscle Contraction or Tone | PE | has_pe | epinephrine |
| MEDRT | N0000009070 | Hemostasis Alteration | PE | has_pe | epinephrine |
| MEDRT | N0000178478 | Increased Blood Pressure | PE | has_pe | epinephrine |
| MEDRT | N0000175976 | Local Anesthesia | PE | has_pe | lidocaine hydrochloride |
| MEDRT | N0000175976 | Local Anesthesia | PE | has_pe | lidocaine |
| MEDRT | N0000009808 | Positive Chronotropy | PE | has_pe | epinephrine |
| MEDRT | N0000009809 | Positive Inotropy | PE | has_pe | epinephrine |
| MEDRT | N0000009820 | Pupillary Dilation | PE | has_pe | epinephrine |
Properties#
Category, Property, Value table| Category | Property | Value |
|---|
| ATTRIBUTES | AVAILABLE_STRENGTH | 0.005 MG/ML / 20 MG/ML |
| ATTRIBUTES | GENERAL_CARDINALITY | MULTI |
| ATTRIBUTES | HUMAN_DRUG | US |
| ATTRIBUTES | PRESCRIBABLE | Y |
| ATTRIBUTES | QUANTITY | 20 ML |
| ATTRIBUTES | RXNAV_HUMAN_DRUG | US |
| ATTRIBUTES | SCHEDULE | 0 |
| ATTRIBUTES | TTY | SBD |
| CODES | MMSL_CODE | MTH_RXN_BD14950 |
| CODES | NDA | NDA006488 |
| CODES | RxCUI | 1010692 |
| CODES | SPL_SET_ID | ba082c2f-64f4-419d-9c88-74f203316e17 |
| CODES | SPL_SET_ID | cfcc8a07-b40c-476d-9a21-83487318ac85 |
| NAMES | Prescribable Synonym | Xylocaine 2 % / EPINEPHrine 1:200,000 in 20 ML Injection |
| NAMES | RXNAV_STR | Xylocaine 2 % / EPINEPHrine 1:200,000 per 20 ML Injection |
| NAMES | RxNorm Name | 20 ML epinephrine 0.005 MG/ML / lidocaine hydrochloride 20 MG/ML Injection [Xylocaine with Epinephrine] |
| NAMES | RxNorm Synonym | Xylocaine 2 % / EPINEPHrine 1:200,000 per 20 ML Injection |
| NAMES | Tallman Synonym | 20 ML EPINEPHrine 0.005 MG/ML / lidocaine hydrochloride 20 MG/ML Injection [Xylocaine with EPINEPHrine] |
| NAMES | Tallman Synonym | Xylocaine 2 % / EPINEPHrine 1:200,000 per 20 ML Injection |
| SOURCES | Source | Gold Standard Alchemy |
| SOURCES | Source | Metathesaurus FDA Structured Product Labels |
| SOURCES | Source | Micromedex RED BOOK |
| SOURCES | Source | Multum MediSource Lexicon |